Haemonetics (HAE) Total Current Liabilities (2010 - 2026)

Haemonetics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $282.6 million for Q1 2026.

• In Q1 2026, Total Current Liabilities fell 51.12% year-over-year to $282.6 million; the TTM figure through Mar 2026 stood at $282.6 million (down 51.12% YoY), while the FY2026 annual figure was $282.6 million, down 51.12% from the prior year.
• Total Current Liabilities was $282.6 million for Q1 2026 at Haemonetics, down from $539.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $578.1 million in Q1 2025 to a low of $180.5 million in Q3 2022.
• Historically, Total Current Liabilities has averaged $336.1 million across 5 years, with a median of $269.1 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Total Current Liabilities jumped 113.19% in 2025, then sank 51.12% in 2026.
• A 5-year view of Total Current Liabilities shows it stood at $226.9 million in 2022, then rose by 15.37% to $261.8 million in 2023, then decreased by 3.26% to $253.2 million in 2024, then surged by 113.19% to $539.9 million in 2025, then sank by 47.65% to $282.6 million in 2026.
• The last three Total Current Liabilities figures came in at $282.6 million (Q1 2026), $539.9 million (Q4 2025), and $548.3 million (Q3 2025), per Business Quant data.